Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Press Release

Woodcock’s Role in Aducanumab’s Approval Must Be Investigated as Part of IG Probe

WASHINGTON -

Acting U.S. Food and Drug Administration (FDA) Commissioner Janet Woodcock announced today that she has asked the U.S. Department of Health and Human Services (HHS) Acting Inspector General (IG) to investigate the “interactions between Biogen and the FDA during the process leading to the decision to approve” aducanumab for treatment of Alzheimer’s disease. On January 28, Public Citizen sent a letter to Dr. Woodcock urging her to endorse our call for an HHS OIG investigation of this unprecedented, inappropriately close collaboration between the FDA and Biogen. Dr. Michael Carome, director of Public Citizen’s Health Research Group, released the following statement:

“Public Citizen welcomes Dr. Woodcock’s belated request for an independent IG investigation of her agency’s inappropriately close collaboration with Biogen, as we had urged her to do nearly six months ago.

“Such an investigation must be broad and determine when Dr. Woodcock first became aware of this collaboration and whether she ever specifically endorsed or facilitated it in any way. The IG also must examine how Dr. Woodcock fostered a culture within the FDA’s Center for Drug Evaluation and Research that permitted and encouraged such an inappropriate collaboration with regulated industry. Under her leadership over the past three decades, the relationship between the FDA and the pharmaceutical industry has grown ever cozier — resulting in regulatory capture of the agency by industry.

“It is also imperative that Congress proceed expeditiously with its own announced investigation of the FDA-Biogen collaboration to ensure a thorough assessment and public airing of the circumstances that lead to the FDA’s reckless and inexcusable decision to approve aducanumab.”

###

Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people – not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

Coalition Sues Biden EPA Over Approval of 'Highly Toxic' Pesticide Linked to Parkinson's

"This paraquat registration puts EPA on the wrong side of science, history, and the law."

Andrea Germanos ·


Hundreds of Thousands Take to Streets Worldwide for 'Uproot the System' Climate Strikes

"The climate crisis has not disappeared," said Swedish activist Greta Thunberg. "It's the opposite—it's even more urgent now than it was before."

Jake Johnson ·


African Leaders Condemn Vaccine Apartheid as an 'Indictment on Humanity'

"We tend to forget that no one is safe until everyone is safe."

Jake Johnson ·


As Other States Try to Copy Texas, SCOTUS Asked to Find Abortion Ban Unconstitutional

The request from healthcare providers comes after a Florida Republican filed a copycat bill and advocacy groups called on Congress to affirm the right to abortion nationwide.

Jessica Corbett ·


As Bids to Slash Pentagon Budget Fail, US Military Spending Slammed as 'Height of Absurdity'

"Spending $780 billion on weapons and war while our communities starve, while the climate crisis worsens, while a pandemic that has killed millions and affected countless more rages on, is a national shame."

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo